36氪获悉,“Tome Biosciences”宣布公司已在A轮和B轮融资中筹集了2.13亿美元,投资方包括: Andreessen Horowitz(a16z)Bio + Health、ARCH Venture Partners、GV, Longwood Fund, Polaris Partners, Bruker Corporation, FUJIFILM Corporation, Alexandria Venture Investments等。据了解,Tome Biosciences是一家可编程基因组集成(PGI)公司。原文链接